Presentation/Webcast
Latest Presentation
Investors Meeting Presentation
- Jan. 31, 2025 Conference on Q3 FY2024 Financial Results（PDF/3,013KB）
- Jan. 31, 2025 Conference on Q3 FY2024 Financial Results (Webcast, available for 12 months)
- Jan. 31, 2025 Conference on Q3 FY2024 Financial Results transcript（PDF/3,883KB）
Presentation for the Conference on the Establishment of RACTHERA, the Regenerative Medicine and Cell Therapy Business Joint Venture
- Dec. 17, 2024 Presentation Material (Sumitomo Chemical Co., Ltd. )（PDF/671KB）
- Dec. 17, 2024 Presentation Material (Sumitomo Pharma Co., Ltd. )（PDF/552KB）
- Dec. 17, 2024 Conference on the Establishment of RACTHERA, the Regenerative Medicine and Cell Therapy Business Joint Venture (Webcast, available for 12 months)
- Dec. 17, 2024 Conference on the Establishment of RACTHERA, the Regenerative Medicine and Cell Therapy Business Joint Venture transcript（PDF/6,166KB）
Past Presentation
Search by category
FY2024
Financial results for FY2024
- Jan. 31, 2025 Conference on Q3 FY2024 Financial Results（PDF/3,013KB）
- Jan. 31, 2025 Conference on Q3 FY2024 Financial Results (Webcast, available for 12 months)
- Jan. 31, 2025 Conference on Q3 FY2024 Financial Results transcript（PDF/3,883KB）
- Oct. 30, 2024 Conference on Q2 FY2024 Financial Results（PDF/1,396KB）
- Oct. 30, 2024 Conference on Q2 FY2024 Financial Results (Webcast, available for 12 months)
- Oct. 30, 2024 Conference on Q2 FY2024 Financial Results transcript（PDF/4,744KB）
- Jul. 31, 2024 Conference on Q1 FY2024 Financial Results（PDF/957KB）
- Jul. 31, 2024 Conference on Q1 FY2024 Financial Results (Webcast, available for 12 months)
- Jul. 31, 2024 Conference on Q1 FY2024 Financial Results transcript（PDF/3,830KB）
FY2023
Financial results for FY2023
- May 14, 2024 Conference on FY2023 (April 1, 2023 to March 31, 2024) Financial Results（PDF/1,202KB）
- May 14, 2024 Conference on FY2023 (April 1, 2023 to March 31, 2024) Financial Results (Webcast, available for 12 months)
- May 14, 2024 Conference on FY2023 (April 1, 2023 to March 31, 2024) Financial Results transcript（PDF/5,126KB）
- Jan. 31, 2024 Conference on Q3 FY2023 Financial Results（PDF/1,947KB）
- Jan. 31, 2024 Conference on Q3 FY2023 Financial Results transcript（PDF/6,342KB）
- Oct. 31, 2023 Conference on Q2 FY2023 Financial Results（PDF/514KB）
- Oct. 31, 2023 Conference on Q2 FY2023 Financial Results transcript（PDF/4,550KB）
- Jul. 31, 2023 Conference on Q1 FY2023 Financial Results（PDF/608KB）
- Jul. 31, 2023 Conference on Q1 FY2023 Financial Results transcript（PDF/3,972KB）
Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024 Presentation
- May 01, 2024 Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024 （PDF/1,371KB）
- May 01, 2024 Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024 (Webcast, available for 12 months)
- May 01, 2024 Conference on Financial Forecasts Revision for FY2023 and Financial Forecasts for FY2024 transcript（PDF/1,159KB）
FY2022
Financial results for FY2022
- May 15, 2023 Investors Meeting Presentation for FY2022 (Year ended March 31, 2023)（PDF/672KB）
- May 15, 2023 Investors Meeting Presentation for FY2022 (Year ended March 31, 2023) transcript（PDF/8,751KB）
- Jan. 31, 2023 Q3 FY2022 Conference Call（PDF/437KB）
- Jan. 31, 2023 Q3 FY2022 Conference Call transcript（PDF/8,921KB）
- Nov. 01, 2022 Investors Meeting Presentation for Q2 FY2022（PDF/583KB）
- Nov. 01, 2022 Investors Meeting Presentation for Q2 FY2022 transcript（PDF/6,056KB）
- Jul. 29, 2022 Q1 FY2022 Conference Call（PDF/413KB）
- Jul. 29, 2022 Q1 FY2022 Conference Call transcript（PDF/1,785KB）
ESG Meeting (2022)
- Dec. 13, 2022 ESG Meeting (Discussion with Investors)（PDF/408KB）
- Dec. 13, 2022 ESG Meeting (Discussion with Investors) transcript（PDF/3,346KB）
Mid-term Business Plan 2027 Presentation
- Apr. 28, 2023 Mid-term Business Plan 2027（PDF/4,790KB）
- Apr. 28, 2023 Mid-term Business Plan 2027 Presentation transcript（PDF/26,371KB）
FY2021
Financial results for FY2021
- May 16, 2022 Investors Meeting Presentation for FY2021 (Year ended March 31, 2022)（PDF/913KB）
- May 16, 2022 Investors Meeting Presentation for FY2021 (Year ended March 31, 2022) transcript（PDF/3,792KB）
- Jan. 31, 2022 Q3 FY2021 Conference Call（PDF/1,157KB）
- Jan. 31, 2022 Q3 FY2021 Conference Call transcript（PDF/10,336KB）
- Oct. 28, 2021 Investors Meeting Presentation for Q2 FY2021（PDF/1,252KB）
- Oct. 28, 2021 Investors Meeting Presentation for Q2 FY2021 transcript（PDF/2,392KB）
- Jul. 29, 2021 Q1 FY2021 Conference Call（PDF/972KB）
- Jul. 29, 2021 Q1 FY2021 Conference Call transcript（PDF/751KB）
ESG Meeting (2021)
- Dec. 08, 2021 ESG Meeting (Discussion with Investors)（PDF/2,718KB）
- Dec. 08, 2021 ESG Meeting (Discussion with Investors) transcript（PDF/4,744KB）
Frontier Business Meeting - FBO Showcase -
- Sep. 08, 2021 Frontier Business Meeting - FBO Showcase -
- Sep. 08, 2021 Frontier Business Meeting - FBO Showcase - transcript（PDF/18,633KB）
FY2020
Financial results for FY2020
- May 13, 2021 Investors Meeting Presentation for FY2020 (Year ended March 31, 2021) and Revision of Mid-term Business Plan 2022（PDF/2,289KB）
- May 13, 2021 Investors Meeting for FY2020 and Revision of Mid-term Business Plan 2022 transcript（PDF/4,491KB）
- Jan. 28, 2021 Q3 FY2020 Conference Call（PDF/937KB）
- Oct. 29, 2020 Investors Meeting Presentation for Q2 FY2020（PDF/1,169KB）
- Jul. 30, 2020 Q1 FY2020 Conference Call（PDF/1,043KB）
Sumitovant Meeting
- Mar. 23, 2021 Sumitovant Meeting（PDF/6,694KB）
- Mar. 23, 2021 Sumitovant Meeting transcript（PDF/122KB）
ESG Meeting (2020)
- Dec. 18, 2020 ESG Meeting (Discussion with Investors)（PDF/2,407KB）
- Dec. 18, 2020 Panel Discussion and Q&A Session at the ESG Meeting（PDF/115KB）
FY2019
Financial results for FY2019
- May 14, 2020 Investors Meeting Presentation for FY2019（PDF/1,657KB）
- Jan. 30, 2020 Q3 FY2019 Conference Call（PDF/1,386KB）
- Nov. 01, 2019 Investors Meeting Presentation for Q2 FY2019 (April 1 to September 30, 2019) / Definitive Agreement for Strategic Alliance with Roivant Sciences（PDF/1,705KB）
- Jul. 29, 2019 Q1 FY2019 Conference Call（PDF/582KB）
R&D Meeting (2020)
ESG Meeting (2019)
- Nov. 27, 2019 ESG Meeting (Discussion with Investors)（PDF/2,758KB）
- Nov. 27, 2019 Q&A Session at the ESG Meeting (Discussion with Investors)（PDF/141KB）
Memorandum of Understanding for Strategic Alliance with Roivant Sciences
Mid-term Business Plan 2022 Presentation
FY2018
Financial results for FY2018
- May 13, 2019 Investors Meeting Presentation for FY2018（PDF/608KB）
- Jan. 31, 2019 Q3 FY2018 Conference Call（PDF/590KB）
- Oct. 31, 2018 Investors Meeting Presentation for Q2 FY2018（PDF/739KB）
- Jul. 27, 2018 Q1 FY2018 Conference Call（PDF/668KB）
ESG Meeting (2018)
- Nov. 20, 2018 ESG Meeting (Discussion with Investors)
- Nov. 20, 2018 Q&A Session at the ESG Meeting (Discussion with Investors)（PDF/121KB）
FY2017
Financial results for FY2017
- May 14, 2018 Financial Results for FY2017（PDF/878KB）
- Jan. 30, 2018 Financial Results for Q3 FY2017（PDF/1,035KB）
- Oct. 31, 2017 Financial Results for Q2 FY2017（PDF/888KB）
- Jul. 28, 2017 Financial Results for Q1 FY2017（PDF/924KB）
FY2016
Financial results for FY2016
- Financial Results for FY2016 (May 12, 2017)（PDF/1,390KB）
- Third Quarter Financial Results for FY2016 (January 27, 2017)（PDF/1,221KB）
- Second Quarter Financial Results for FY2016 (October 27, 2016)（PDF/1,119KB）
- First Quarter Financial Results for FY2016 (July 27, 2016)（PDF/843KB）
R&D Meeting (2017)
Acquisition of Tolero Pharmaceuticals, Inc.
FY2015
Financial results for FY2015
- Financial Results for FY2015 (May 12, 2016)（PDF/1,175KB）
- Third Quarter Financial Results for FY2015 (January 27, 2016)（PDF/1,385KB）
- Second Quarter Financial Results for FY2015 (October 29, 2015)（PDF/999KB）
- First Quarter Financial Results for FY2015 (July 29, 2015)（PDF/562KB）
R&D Meeting (2015)
-
R&D Meeting (December 9, 2015)（PDF/4,424KB）
Replaced slides of the R&D meeting presentation material as of December 9th (Revised: deleted the images of CT-scan on the slide 63 and 64)
FY2014
Financial results for FY2014
- Financial Results for FY2014 (May 12, 2015)（PDF/1,301KB）
- Third Quarter Financial Results for FY2014 (January 29, 2015)（PDF/1,018KB）
- Second Quarter Financial Results for FY2014 (October 31, 2014)（PDF/819KB）
- First Quarter Financial Results for FY2014 (July 30, 2014)（PDF/344KB）
FY2013
Financial results for FY2013
- Financial Results for FY2013 (May 9, 2014)（PDF/747KB）
- Third Quarter Financial Results for FY2013 (January 31, 2014)（PDF/593KB）
- Second Quarter Financial Results for FY2013 (October 31, 2013)（PDF/842KB）
- First Quarter Financial Results for FY2013 (July 31, 2013)（PDF/366KB）
R&D Meeting (2014)
FY2012
Financial results for FY2012
- Financial Results for FY2012 (May 10, 2013)（PDF/357KB）
- Third Quarter Financial Results for FY2012 (January 31, 2013)（PDF/397KB）
- Second Quarter Financial Results for FY2012 (November 1, 2012)（PDF/663KB）
- First Quarter Financial Results for FY2012 (July 27, 2012)（PDF/287KB）
Third Mid-term Business Plan Presentation
FY2011
Financial results for FY2011
- Financial Results for FY2011 (May 11, 2012)（PDF/679KB）
- Third Quarter Financial Results for FY2011 (February 3, 2012)（PDF/200KB）
- Second Quarter Financial Results for FY2011 (November 1, 2011)(Webcast Version)（PDF/287KB）
- First Quarter Financial Results for FY2011 (July 29, 2011)（PDF/190KB）
Acquisition of Boston Biomedical Inc.
J.P.Morgan Healthcare Conference 2012
FY2010
Financial results for FY2010
- Financial Results for FY2010 (May 12, 2011)（PDF/432KB）
- Third Quarter Financial Results for FY2010 (Apr. 1 to Dec. 31, 2010) (February 3, 2011)（PDF/219KB）
- Second Quarter Financial Results for FY2010 (Apr. 1 to Sep. 30, 2010) (November 2, 2010)（PDF/360KB）
- At the press conference, Second Quarter Financial Results for FY2010 (Apr. 1 to Sep. 30, 2010) (October 29, 2010)（PDF/344KB）
- First Quarter Financial Results for FY2010 (July 30, 2010)（PDF/348KB）
LATUDA® Meeting
- LATUDA® Meeting (January 25, 2011), Clinical Development Update（PDF/419KB）
- LATUDA® Meeting (January 25, 2011), Commercial Update（PDF/370KB）
J.P.Morgan Healthcare Conference 2011
FY2009
Financial results for FY2009
- Financial Results for FY2009 (May 11, 2010)（PDF/338KB）
- Third Quarter Financial Results for FY2009 (February 3, 2010)（PDF/270KB）
- Second Quarter Financial Results for FY2009 (October 29, 2009)（PDF/238KB）
- First Quarter Financial Results for FY2009 (July 31, 2009)（PDF/224KB）
Second Mid-term Business Plan -FY2010 to FY2014-
Sepracor Inc. Company Overview
- Sepracor Inc. Company Overview -November 12, 2009（PDF/1,049KB）
- (Reference) Sepracor Factbook 2009（PDF/1,573KB）
Acquisition of Sepracor Inc.
Lurasidone Meeting
FY2008
Financial results for FY2008
- Financial Results for FY2008 (May 12, 2009)（PDF/444KB）
- Third Quarter Financial Results for FY2008 (Feb. 3, 2009)（PDF/220KB）
- Second Quarter Financial Results for FY2008 (October 31, 2008)（PDF/262KB）
- First Quarter Financial Results for FY2008 (July 31, 2008)（PDF/220KB）
FY2007
Financial results for FY2007
- Financial Results for FY2007 (May 12, 2008)（PDF/508KB）
- Third Quarter Financial Results for FY2007 (Feb. 1, 2008)（PDF/211KB）
- First Half Financial Results for FY2007 (Nov. 8, 2007)（PDF/275KB）
- Consolidated Financial Results for 1st Quarter of FY2007 (July 30, 2007)（PDF/216KB）
FY2006
Financial results for FY2006
- Financial Results for FY2006 (May 11, 2007)（PDF/290KB）
- Consolidated Financial Results for 3rd Quarter of FY2006 (Feb. 2, 2007)（PDF/292KB）
- First Half Financial Results for FY2006 (Nov. 9, 2006)（PDF/350KB）
- R&D Strategy for diabetes (Nov. 9, 2006)（PDF/255KB）
- Financial Results for the First Quarter of FY2006 (July 28, 2006)（PDF/214KB）